country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-119340

Copy Link Print Information

Mitoflaxone

(Synonyms: Flavoneacetic acid)

Mitoflaxone (flavoneacetic acid) is a synthetic flavonoid compound with vascular targeting properties. Mitoflaxone exerts anti-proliferative effects on endothelial cells through a superoxide-dependent mechanism, this effect leads to changes in the permeability of tumor blood vessels, thereby exerting anti-tumor effects^{[1]^{^{[2]^.}}}

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 87626-55-9
Formel: C₁₇H₁₂O₄
Molecular Weight:280.27

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (268 KB)

Mitoflaxone Chemical Structure

CAS. Nr.: 87626-55-9

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Cellular Effect

Cell Line	Type	Value	Description	References
2008	IC₅₀	421.3 μM Compound: FAA (Flavone -8-acetic acid)	Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells	[PMID: 12904070]
A549	IC₅₀	341.5 μM Compound: 2, FAA	Cytotoxicity against human A549 cells after 24 hrs by MTT assay Cytotoxicity against human A549 cells after 24 hrs by MTT assay	[PMID: 24518295]
C13	IC₅₀	233.3 μM Compound: FAA (Flavone -8-acetic acid)	Direct cytotoxicity against the selected tumor cell line c13* was determined especially on ovarian adenocarcinoma derived cells Direct cytotoxicity against the selected tumor cell line c13* was determined especially on ovarian adenocarcinoma derived cells	[PMID: 12904070]
DLD-1	IC₅₀	>500 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit DLD1 cells In vitro concentration required to inhibit DLD1 cells	10.1016/0960-894X(94)85031-3
HCT-8	IC₅₀	245 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit HCT18 cells In vitro concentration required to inhibit HCT18 cells	10.1016/0960-894X(94)85031-3
HT-29	IC₅₀	2449.5 μM Compound: 2, FAA	Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay	[PMID: 24518295]
HT-29	IC₅₀	390 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit HT-29 cells In vitro concentration required to inhibit HT-29 cells	10.1016/0960-894X(94)85031-3
K562	IC₅₀	310 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit K562 cells In vitro concentration required to inhibit K562 cells	10.1016/0960-894X(94)85031-3
LoVo	IC₅₀	378.3 μM Compound: FAA (Flavone -8-acetic acid)	In vitro cytotoxicity against the selected tumor cell line LoVoR arising from human colon adenocarcinoma was determined In vitro cytotoxicity against the selected tumor cell line LoVoR arising from human colon adenocarcinoma was determined	[PMID: 12904070]
LoVo	IC₅₀	563.9 μM Compound: FAA (Flavone -8-acetic acid)	In vitro cytotoxicity against the selected tumor cell line LoVoS arising from human colon adenocarcinoma was determined In vitro cytotoxicity against the selected tumor cell line LoVoS arising from human colon adenocarcinoma was determined	[PMID: 12904070]
MAC15A	IC₅₀	150 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit MAC 15 A cells In vitro concentration required to inhibit MAC 15 A cells	10.1016/0960-894X(94)85031-3
MAC16	IC₅₀	180 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit MAC 16 cells In vitro concentration required to inhibit MAC 16 cells	10.1016/0960-894X(94)85031-3
MAC26	IC₅₀	208 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit MAC 26 cells In vitro concentration required to inhibit MAC 26 cells	10.1016/0960-894X(94)85031-3

Chemical Information

CAS. Nr. 87626-55-9
Molecular Weight 280.27
Formel C₁₇H₁₂O₄
SMILES

O=C1C2=C(C(CC(O)=O)=CC=C2)OC(C3=CC=CC=C3)=C1
Synonyms

Flavoneacetic acid
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (268 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Mitoflaxone. In subject area: Pharmacology, Toxicology and Pharmaceutical Science.

[2]. Yadav RP, et al. Purification and characterization of a regiospecific lipase from Aspergillus terreus. Biotechnology and applied biochemistry. 1998 Dec;28(3):243-9.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen